Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients

• Үндсэн зохиолчид: Guy Rostoker (Зохиогч), Fanny Lepeytre (Зохиогч), Myriam Merzoug (Зохиогч), Mireille Griuncelli (Зохиогч), Christelle Loridon (Зохиогч), Ghada Boulahia (Зохиогч), Yves Cohen (Зохиогч)
• Формат: Ном
• Хэвлэсэн: MDPI AG, 2022-07-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Anemia is a major complication of end-stage kidney disease (ESKD). Erythropoiesis-stimulating agents and intravenous (IV) iron are the current backbone of anemia treatment in ESKD. Iron overload induced by IV iron is a potential clinical problem in dialysis patients. We compared the pharmacokinetics...